胚胎干细胞、成体干细胞、肿瘤干细胞、间充质干细胞与 iPSCs（含 iPSC 衍生细胞），配套专用培养基与诱导方案。 共 669 个产品。
iPSCs from healthy infant tissue are ideal for stem cell research, developmental biology, and drug discovery, providing reproducible and reliable models.
HighQC™ Human Induced Pluripotent Stem Cells, From Muscular Dystrophy, are derived from patients with Muscular Dystrophy and reprogrammed using a non-integrating episomal vector system. Reprogramming is achieved through transient expression of a defined combination of transcription factors, typically including OCT4, SOX2, KLF4, and c-MYC. These cells retain robust differentiation potential, capable of generating cell lineages representative of the three germ layers—ectoderm, mesoderm, and endoderm—through directed differentiation protocols. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
HighQC™ human induced pluripotent stem cells derived from fibroblasts of Parkinson's disease patients are generated using an RNA-based Sendai virus. These cells express pluripotency markers such as OCT4 and SSEA4. Cytogenetic analysis demonstrates a normal human karyotype and long-term genetic stability across multiple passages. These cells retain full differentiation capacity, enabling their directed differentiation into all three germ layers—ectoderm, mesoderm, and endoderm—under appropriate conditions. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
HighQC™ Human Induced Pluripotent Stem Cells, From Rett Syndrome, are generated using a non-integrating Sendai virus vector system to deliver a defined set of reprogramming transcription factors, typically including OCT4, SOX2, KLF4, and c-MYC. These cells display typical pluripotent stem cell characteristics, including a high nucleus-to-cytoplasm ratio and prominent nucleoli. The donor carries a frameshift mutation (1155del32) in the MECP2 gene, characteristic of Rett Syndrome. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
HighQC™ Human Induced Pluripotent Stem Cells, From Schizophrenia, are derived from patients diagnosed with schizophrenia. These cells are generated using lentiviral vectors to deliver reprogramming factors to fibroblasts and are cultured under a feeder layer. These cells are generated by transducing four transcription factors, Oct3/4, Sox2, Klf4, and c-Myc, into skin fibroblasts using non-integrating methods. They express key pluripotency markers such as OCT4 and SSEA-4. These cells retain the full differentiation potential to generate all three germ layers — ectoderm, mesoderm, and endoderm — enabling the development of relevant neural cell types, including cortical neurons and glial cells. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
HighQC™ Human Induced Pluripotent Stem Cells, From Spinal Muscular Atrophy, are derived from patients with Spinal Muscular Atrophy Type II (SMA) and generated by reprogramming somatic cells using integrating lentiviral vectors encoding a defined set of pluripotency-associated transcription factors, including OCT4, SOX2, NANOG, and LIN28. These iPSCs exhibit characteristic pluripotent stem cell morphology, such as a high nucleus-to-cytoplasm ratio and prominent nucleoli. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
HighQC™ human induced pluripotent stem cells (iPSCs) from Tay-Sachs disease patients are derived from patient fibroblasts carrying disease-specific HEXA mutations. These cells exhibit classical pluripotent stem cell morphology. They are generated by transducing four transcription factors OCT4, SOX2, KLF4, and c-MYC into patient fibroblasts using Sendai virus. The expanded line was evaluated for viability surface antigen expression and alkaline phosphatase activity. Pluripotency was assessed via embryoid body (EB) formation. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
Discover HighQC™ Human Induced Pluripotent Stem Cells derived from urine, offering solutions for research and regenerative medicine applications.
Human Inferior Mesenteric Plexus Neuronal Stem Cell; Frozen Vial and Plated cells are available.
HighQC™ Human IPS Cell (Episomal/Diabetes Type II/Adipose) supports disease modeling, drug screening and regenerative research for PD and type II diabetes.
HighQC™ Human iPSCs (iPSC From Adipose/ Parkinson/ Episomal) are integration-free induced pluripotent stem cells derived from adipose tissue fibroblasts through episomal reprogramming. Reprogramming is achieved through episomal delivery of defined transcription factors, including OCT4, SOX2, KLF4, c-MYC, and LIN28. These cells express pluripotency markers including OCT4, NANOG, SSEA-4, and TRA-1-60, and can efficiently differentiate into functionally active dopaminergic neurons, a key neuronal subtype affected in Parkinson's disease. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
HighQC™ Human iPSCs (iPSC From Fibroblast/ Diabetes Type II/ Episomal) are a type of disease-specific induced pluripotent stem cell line derived from dermal fibroblasts of a Type 2 Diabetes Mellitus (T2D) donor. Reprogramming was achieved via episomal delivery. These cells exhibit high expression of pluripotency markers such as SOX2, TRA-1-60, OCT4, and SSEA-4, and display typical colony morphology with high nucleus-to-cytoplasm ratios. They retain the capacity to differentiate into cells of all three germ layers, including insulin-producing pancreatic β-cells. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
HighQC™ Human iPSCs (iPSCs From Fibroblasts / Parkinson’s Disease / Episomal) are induced pluripotent stem cells derived from dermal fibroblasts. The cells express canonical stem cell markers including TRA-1-60, SOX2, OCT4, NANOG, and SSEA-4, confirming the maintenance of a stable undifferentiated state. They display robust trilineage differentiation capacity and can be directed toward midbrain dopaminergic neurons and glial subtypes, making them a valuable human model for Parkinson's disease. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
HighQC™ Human IPS Cell (IPSC From PBMC/ Diabetes Type II/ Episomal) enables T2D and Parkinson’s modeling for regenerative research and drug screening.
ImmunoClone offers human iPS cell lines derived from PBMCs of patients with Parkinson's Disease.
HighQC™ Human IPS Cells (Parkinson's Disease) exhibit typical human pluripotent stem cell characteristics, including a compact colony structure with defined edges and a high nucleus-to-cytoplasm ratio. These cells are generated by transducing four transcription factors, Oct3/4, Sox2, Klf4, and c-Myc, into somatic cells of clinically diagnosed PD patients using integration-free methods. Molecular characterization confirms the expression of key pluripotency markers such as OCT4, SOX2, NANOG, SSEA4 and TRA-1-60. They possess broad differentiation potential, enabling differentiation into all embryonic germ layers, including ectoderm, mesoderm, and endoderm. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
HighQC™ Human IPS Cells (SOD1 Mutation/A4V) are induced pluripotent stem cells (iPSCs) derived from donor somatic cells. The cells exhibit typical pluripotent stem cell morphology, including high nuclear-to-cytoplasmic ratios, prominent nucleoli, and tightly packed colonies with defined edges. These cells are generated by transducing four transcription factors, Sox2, Oct4, Klf4, and c-Myc, into somatic cells. The SOD1 A4V mutation, a well-known pathogenic variant in familial ALS, is verified by sequencing and remains stable in culture. These cells can differentiate into three germ layers in vitro and in vivo. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
HighQC™ Human iPSCs (Type 2 Diabetes) are disease-specific induced pluripotent stem cells derived from dermal fibroblasts of a clinically confirmed Type 2 Diabetes (T2D) donor. These cells were reprogrammed from dermal fibroblasts using non-integrating vectors. The cells maintain the capacity to differentiate into glucose-responsive cell types, including pancreatic β-cells and insulin-sensitive hepatocytes, making them a physiologically relevant model for metabolic disease research. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
ImmunoClone's footprint-free human iPS (induced pluripotent stem) cell line with APOE knockout (KO) was derived from the ImmunoClone's iPSC line.
Induced Pluriopotent Stem Cells (iPSCs) are a type of pluripotent stem cells that can be directly derived from adult somatic cells. The derived iPSCs can propagate indefinitely, as well as give rise to other cell types in the body. iPSCs hold great promise in the field of regenerative medicine by representing a single source of cells that could be used to replace those damaged/diseased cells. These iPSCs are established from a single clone and expanded under feeder-free conditions.
HighQC™ Human IPS Cell Line (Episomal, CD34+, ApoE4) supports neurodegeneration and cardiovascular risk studies using footprint-free reprogramming.
Footprint-free human iPS (induced pluripotent stem) cell line derived from human foreskin fibroblasts (HFFs).
HighQC™ Human IPS Cell Line (Episomal, MSC) supports cell differentiation, regenerative medicine, and disease modeling with footprint-free iPSC technology.
Human iPSC Derived AFE Progenitors provide high-quality, defined cells for endodermal lineage differentiation, regenerative therapy, and disease modeling.
共 669 个产品 ｜ 第 9 / 28 页
